1.Proteomics and its application in the studies of orthopedic disease
Yufu WU ; Zuozhen YIN ; Jielile JIASHARETE ; Guangzhong YANG
Journal of Medical Postgraduates 2003;0(07):-
Proteomics is a new field of research in the post-genomic era,which aims at the expression and functional study of proteins in cells,tissues and organisms.It analyses the vital changes of pathological and physiological processes of life by examining proteins.It can detect low-abundance or low molecular weight proteins and polypeptides which contain rich information about diagnosis,treatment and prognosis of diseases,leading to important breakthrough in the field of basic and clinical researches.It has achieved great progress and displayed a promising future in orthopedic researches.This article reviews the development,the present status of proteomic research and its application in orthopedics.
2.Effect ofGuizhi-Fulingcapsule on expression of AngⅡ, eNOS in rats with UUO-induced tubulointerstitial fibrosis
Shujun LI ; Jianjun LIU ; Yan ZHANG ; Xiyan JIA ; Zuozhen CHAI ; Dasheng YANG
International Journal of Traditional Chinese Medicine 2015;(8):724-727
Objectives To observe the effect ofGuizhi-Fuling capsule on the expression of AngⅡand eNOS.Methods 72 male Sprague-Dawley(SD) rats, aged three months, were randomly divided into three groups: a sham-operated group(n=24),a model group (n=24) and a treatment group (n=24). Renal tubulointerstitial fibrosis model was established via unilateral ureteral obstruction(UUO). Rats in the treatment group were treated withGuizhi-Fulingcapsule (125mg/kg),and the same volume of normal saline were given to the rats in the sham -operated group and the model group at the same time. Rats were put to death at day 7, 14, 21 Immunohisto-chemistry staining was performed to investigate both the expression of AngⅡ, eNOS in TIF. Results 1 Renal interstitium injury was seen in the model group and the treatment group rats at day 7. The degree of renal interstitium fibrosis in rats from the treatment group was lighter than that of the model group at day 7, 14, 21 (P< 0.01).2 At day 7,14 and 21, the expression of AngⅡin rats from the model group and the treatment group were higher than that of the sham-operated group (P<0.01), but those of the treatment group was lower than those of the model group (P< 0.01). The expression of AngⅡ in rats from the model and the treatment groups were increasing,the highest in the 21th day (P<0.01).3 At day 7, 14 and 21, the expression of eNOS in rats from the model group and the treatment group were lower than that of the sham-operated group (P<0.01).ConclusionsGuizhi-Fuling capsule can alleviate the lesion of renal tissue in obstructive kidney and delay the development of TIF.
3.Analysis of clinical features and ZBTB18 gene variant in a child with autosomal dominant mental disorder type 22.
Jia ZHANG ; Yang LI ; Huan LUO ; Yajun SHEN ; Meng YUAN ; Zuozhen YANG ; Jing GAN
Chinese Journal of Medical Genetics 2022;39(3):293-296
OBJECTIVE:
To analyze the clinical characteristics and ZBTB18 gene variant in a child with epilepsy and global developmental delay.
METHODS:
Clinical data and laboratory examination of the patient were reviewed. Whole exome sequencing (WES) was also carried out for the family trio.
RESULTS:
The main manifestations of the child included global developmental delay, short stature, epileptic seizures. EEG revealed frequent occurrence of sharp (slow) waves in the right central region during sleeping, with sharp waves occasionally seen in the frontal and right posterior temporal regions. Cranial MRI has shown no obvious abnormality. WES has identified a de novo pathogenic variant in the ZBTB18 gene [NM_205768.3: exon 2: c.1282_1283del (p.Phe428Leufs*72)]. Based on the guidelines from American College of Medical Genetics and Genomics (ACMG), the variant was classified as pathogenic (PS2+PVS1_Moderate+PM2_Supporting). Following treatment with levetiracetam and rehabilitation, the seizures have been controlled for nearly half a year, with improvement of the psychomotor and language development. So far 28 children have been discovered with ZBTB18 gene mutations, and there was a significant difference in the clinical phenotypes of motor retardation, language retardation and epilepsy between those harboring frameshift/nonsense mutations and missense mutations.
CONCLUSION
The c.1282_1283del (p.Phe428leufs *72) variant of the ZBTB18 probably underlay the autosomal dominant mental disorder type 22 in this child. Compared with missense mutations, frameshift/nonsense mutations may predispose more to motor retardation, delayed language development and epilepsy.
Codon, Nonsense
;
Epilepsy/genetics*
;
Humans
;
Intellectual Disability/genetics*
;
Mutation
;
Whole Exome Sequencing
4.De novo variant of CSNK2B causes Poirier-Bienvenu neurodevelopmental syndrome: two case report.
Jia ZHANG ; Yang LI ; Huan LUO ; YaJun SHEN ; Meng YUAN ; Zuozhen YANG ; Jing GAN
Chinese Journal of Medical Genetics 2022;39(5):484-487
OBJECTIVE:
To analyze the clinical characteristics and CSNK2B gene variant of 2 children with Poirier-Bienvenu neurodevelopmental syndrome, and to identify the possible pathogenic causes and provide evidence for clinical diagnosis.
METHODS:
Two children with Poirier-Bienvenu neurodevelopmental syndrome were selected from West China Second University Hospital, Sichuan University. The clinical manifestations, laboratory examination and CSNK2B gene variant were analyzed.
RESULTS:
The main manifestations of 2 children were epilepsy, motor or intellectual retardation. Whole exon sequencing showed that CSNK2B gene c. 291+4A>T heterozygous splicing variant was found in case one, and CSNK2B copy number variation(CNV) was lost in case two. Case one received no special treatment, followed up for 8+ months, seizures and motor development were improved; case two had recurrent seizures for 9+ years, and received levetiracetam and clonazepam antiepileptic treatment. No seizures have occurred for 2 years now, and a large number of epileptic discharges can still be seen in video electroencephalogram (VEEG) with slightly backward intelligence and language development.
CONCLUSION
Our study further proves that the pathogenic variant of CSNK2B is related to epilepsy with developmental disorder, and enrich is the CSNK2B gene variant spectrum. The pathogenesis of CSNK2B has great clinical heterogeneity, with great difference in severity of nervous system injury and different prognosis, and agenesis of corpus callosum may be one of its clinical phenotypes.
Child
;
DNA Copy Number Variations
;
Developmental Disabilities/genetics*
;
Epilepsy/genetics*
;
Humans
;
Intellectual Disability/genetics*
;
Seizures/genetics*
5.Analysis of clinical characteristics and ATP7A gene variants in a Chinese pedigree affected with Menkes disease.
Jia ZHANG ; Jing GAN ; Zuozhen YANG ; Jianjun WANG
Chinese Journal of Medical Genetics 2023;40(12):1504-1507
OBJECTIVE:
To explore the clinical characteristics and variants of ATP7A gene in a child with Menkes disease.
METHODS:
A child with Menkes disease diagnosed at the West China Second Hospital of Sichuan University and its family members in March 2022 was selected as the study subjects. Clinical manifestations and results of laboratory tests and genetic testing were summarized.
RESULTS:
The main manifestations of the child included seizures, global development delay, facial dysmorphism, sparse and curly hair, increased lactate and pyruvate, and significantly decreased cuprin. EEG showed frequent issuance of multifocal spikes, spines, polyspines (slow) and polymorphic slow waves. Multiple tortuous vascular shadows were observed on cranial MRI. Whole exome sequencing revealed that the child has harbored a hemizygous c.3076delA (p.ile1026*) variant of the ATP7A gene, which was inherited from his mother. The variant may lead to premature termination of protein translation. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), the variant was predicted as pathogenic (PVS1+PM2+PP4).
CONCLUSION
The c.3076delA (p.Ile1026*) variant of the ATP7A gene probably underlay the Menkes disease in this child. Above finding has provided evidence for clinical diagnosis. The significantly increased lactic acid and pyruvate can be used as a reference for the diagnosis and management of Menkes disease. Microscopic abnormalities in the hair of the carriers may also facilitate their diagnosis.
Child
;
Humans
;
Copper-Transporting ATPases/genetics*
;
East Asian People
;
Menkes Kinky Hair Syndrome/genetics*
;
Mutation
;
Pedigree
;
Peptide Fragments
;
Pyruvic Acid
6.Analysis of a case with Xia-Gibbs syndrome due to variant of AHDC1 gene.
Lijuan FAN ; Yang LI ; Huan LUO ; Yajun SHEN ; Meng YUAN ; Zuozhen YANG ; Jing GAN
Chinese Journal of Medical Genetics 2022;39(4):397-400
OBJECTIVE:
To analyze the clinical and genetic characteristics of a child featuring Xia-Gibbs syndrome.
METHODS:
Whole exome sequencing was carried out for the child.
RESULTS:
The patient has presented with developmental delay, hypotonia, strabismus and snoring. Cranial MRI revealed hypomyelination, while the EEGs were normal. Genetic testing revealed a de novo variant of the AHDC1 gene, namely c.730delA (p.Ile244Serfs*16), which was classified as pathogenic (PVS1+PS2+PM2). Together with 60 cases from the literature, individuals harboring a AHDC1 variant commonly have delayed motor milestones, speech delay, facial dysmorphism and hypotonia. Dysgenesis of corpus callosum is also common. In total 47 AHDC1 variants have been reported, among which truncating variants were the most common type.
CONCLUSION
The c.730delA (p.Ile244Serfs*16) variant of the AHDC1 gene probably underlay the Xia-Gibbs syndrome in this patient. Above finding has provided a basis for the clinical diagnosis.
Abnormalities, Multiple/genetics*
;
Child
;
DNA-Binding Proteins/genetics*
;
Humans
;
Intellectual Disability/genetics*
;
Muscle Hypotonia
;
Mutation
;
Whole Exome Sequencing
7.Genetic analysis of a child with Charlevoix-Saguenay spastic ataxia due to variant of SACS gene.
Huan LUO ; Xiaolu CHEN ; Xueyi RAO ; Yajun SHEN ; Jinfeng LIU ; Zuozhen YANG ; Jing GAN
Chinese Journal of Medical Genetics 2023;40(5):558-562
OBJECTIVE:
To explore the clinical feature and genetic variant of a child with autosomal recessive Charlevoix-Saguenay type spastic ataxia (ARSACS).
METHODS:
Clinical data of a child who was admitted to the West China Second Hospital of Sichuan University on April 30, 2021 was collected. Whole exome sequencing (WES) was carried out for the child and his parents. Candidate variants were verified by Sanger sequencing and bioinformatic analysis based on the guidelines from the American College of Medical Genetics and Genomics (ACMG).
RESULTS:
The child, a 3-year-and-3-month-old female, had a complain of "walking instability for over a year". Physical and laboratory examination revealed progressive and aggravated gait instability, increased muscle tone of the right limbs, peripheral neuropathy of the lower limbs, and thickening of retinal nerve fiber layer. The results of WES revealed that she has harbored a maternally derived heterozygous deletion of exons 1 to 10 of the SACS gene, in addition with a de novo heterozygous c.3328dupA variant in exon 10 of the SACS gene. Based on the ACMG guidelines, the exons 1-10 deletion was rated as likely pathogenic (PVS1+PM2_Supporting), and the c.3328dupA was rated as a pathogenic variant (PVS1_Strong+PS2+PM2_Supporting). Neither variant was recorded in the human population databases.
CONCLUSION
The c.3328dupA variant and the deletion of exons 1-10 of the SACS gene probably underlay the ARSACS in this patient.
Female
;
Humans
;
Heat-Shock Proteins/genetics*
;
Muscle Spasticity/genetics*
;
Mutation
;
Spinocerebellar Ataxias/pathology*
;
Child, Preschool